Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04435756 · ClinicalTrials.gov registry record

A Study of miRNA 371 in Patients With Germ Cell Tumors

A clinical trial of Germ Cell Tumor and Seminoma, sponsored by SWOG Cancer Research Network.

Active
Registry status
956
Enrollment target
20
Study locations

NCT04435756 is a study of Germ Cell Tumor and Seminoma that is active but no longer recruiting, run by SWOG Cancer Research Network. The registered enrollment target is 956 participants, above the 297-participant average among 19 other Germ Cell Tumor trials with a reported enrollment target (222% higher). The trial reports 20 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04435756, a study of Germ Cell Tumor and Seminoma, is active but no longer recruiting, sponsored by SWOG Cancer Research Network.

ACTIVE NOT RECRUITING
Registry status
956 participants
Enrollment target
20
Study locations

Study Summary

This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers. Studying samples of blood from patients with germ cell cancers in the laboratory may help doctors predict how likely the cancer will come back.

Conditions Studied

Germ Cell Tumor Seminoma Metachronous Malignant Neoplasm Stage I Testicular Cancer AJCC v8 Stage IA Testicular Cancer AJCC v8 Stage IB Testicular Cancer AJCC v8 Stage IS Testicular Cancer AJCC v8

Interventions

  • OTHER Biomarker Analysis
  • PROCEDURE Blood Product Collection

Study Locations (20)

California

  • Kaiser Permanente-Anaheim - Anaheim
  • Kaiser Permanente-Deer Valley Medical Center - Antioch
  • PCR Oncology - Arroyo Grande
  • Kaiser Permanente-Baldwin Park - Baldwin Park
  • Kaiser Permanente-Bellflower - Bellflower
  • Keck Medicine of USC Buena Park - Buena Park
  • Epic Care-Dublin - Dublin
  • Kaiser Permanente Dublin - Dublin
  • Bay Area Breast Surgeons Inc - Emeryville
  • Epic Care Partners in Cancer Care - Emeryville
  • Kaiser Permanente-Fontana - Fontana
  • Kaiser Permanente-Fremont - Fremont
  • Fresno Cancer Center - Fresno
  • Kaiser Permanente-Fresno - Fresno

Arizona

  • Banner MD Anderson Cancer Center - Gilbert
  • Kingman Regional Medical Center - Kingman
  • University of Arizona Cancer Center-Orange Grove Campus - Tucson
  • Banner University Medical Center - Tucson - Tucson
  • University of Arizona Cancer Center-North Campus - Tucson

Arkansas

  • Mercy Hospital Fort Smith - Fort Smith

Trial Details

FieldValue
Enrollment Target 956 participants
Start Date 2020-07-28
Est. Completion 2028-01-01

Sponsor

SWOG Cancer Research Network

270 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04435756

The ClinicalTrials.gov registry entry for NCT04435756 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 956 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 297-participant average among 19 other Germ Cell Tumor trials with a reported enrollment target (222% higher). The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Germ Cell Tumor appearing as the primary indexed condition, and to 2 interventions - of which Biomarker Analysis is the first listed.

NCT04435756 reports 20 study locations spanning 3 distinct geographic areas - top geographies include California, Arizona, Arkansas.

Frequently Asked Questions

What is clinical trial NCT04435756 about?

NCT04435756 is a clinical study titled "A Study of miRNA 371 in Patients With Germ Cell Tumors". This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers. Studying samples of blood from patients with germ cell cancers in the laboratory may help doctors predict how likely the cancer will come back...

What is the current status of trial NCT04435756?

This trial is currently active not recruiting. The enrollment target is 956 participants. The study started on 2020-07-28. Estimated completion is 2028-01-01.

What conditions does trial NCT04435756 study?

This clinical trial studies the following conditions: Germ Cell Tumor, Seminoma, Metachronous Malignant Neoplasm, Stage I Testicular Cancer AJCC v8, Stage IA Testicular Cancer AJCC v8.

What interventions are being tested in trial NCT04435756?

The interventions under investigation include: Biomarker Analysis (OTHER), Blood Product Collection (PROCEDURE).

Who is sponsoring clinical trial NCT04435756?

This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04435756 being conducted?

This trial has 20 study locations across Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Germ Cell Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Germ Cell Tumor

All registered trials for this condition

Seminoma

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.